Post-approval study confirms improved survival with HeartMate II LVAD – Healio
Post-approval study confirms improved survival with HeartMate II LVAD
Healio The data were presented at the International Society for Heart and Lung Transplantation Annual Meeting and Scientific Sessions. The post-approval study included the first 247 HeartMate II users (83% men) … “Particularly for patients who do not have … |